Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action - PubMed
- ️Tue Jan 01 2002
Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action
Kenta Hara et al. Cell. 2002.
Free article
Abstract
mTOR controls cell growth, in part by regulating p70 S6 kinase alpha (p70alpha) and eukaryotic initiation factor 4E binding protein 1 (4EBP1). Raptor is a 150 kDa mTOR binding protein that also binds 4EBP1 and p70alpha. The binding of raptor to mTOR is necessary for the mTOR-catalyzed phosphorylation of 4EBP1 in vitro, and it strongly enhances the mTOR kinase activity toward p70alpha. Rapamycin or amino acid withdrawal increases, whereas insulin strongly inhibits, the recovery of 4EBP1 and raptor on 7-methyl-GTP Sepharose. Partial inhibition of raptor expression by RNA interference (RNAi) reduces mTOR-catalyzed 4EBP1 phosphorylation in vitro. RNAi of C. elegans raptor yields an array of phenotypes that closely resemble those produced by inactivation of Ce-TOR. Thus, raptor is an essential scaffold for the mTOR-catalyzed phosphorylation of 4EBP1 and mediates TOR action in vivo.
Similar articles
-
Raptor, a binding partner of target of rapamycin.
Yonezawa K, Tokunaga C, Oshiro N, Yoshino K. Yonezawa K, et al. Biochem Biophys Res Commun. 2004 Jan 9;313(2):437-41. doi: 10.1016/j.bbrc.2003.07.018. Biochem Biophys Res Commun. 2004. PMID: 14684181 Review.
-
Nojima H, Tokunaga C, Eguchi S, Oshiro N, Hidayat S, Yoshino K, Hara K, Tanaka N, Avruch J, Yonezawa K. Nojima H, et al. J Biol Chem. 2003 May 2;278(18):15461-4. doi: 10.1074/jbc.C200665200. Epub 2003 Feb 25. J Biol Chem. 2003. PMID: 12604610
-
TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function.
Schalm SS, Fingar DC, Sabatini DM, Blenis J. Schalm SS, et al. Curr Biol. 2003 May 13;13(10):797-806. doi: 10.1016/s0960-9822(03)00329-4. Curr Biol. 2003. PMID: 12747827
-
Kim DH, Sarbassov DD, Ali SM, Latek RR, Guntur KV, Erdjument-Bromage H, Tempst P, Sabatini DM. Kim DH, et al. Mol Cell. 2003 Apr;11(4):895-904. doi: 10.1016/s1097-2765(03)00114-x. Mol Cell. 2003. PMID: 12718876
-
Kinase activities associated with mTOR.
Yonezawa K, Yoshino KI, Tokunaga C, Hara K. Yonezawa K, et al. Curr Top Microbiol Immunol. 2004;279:271-82. doi: 10.1007/978-3-642-18930-2_16. Curr Top Microbiol Immunol. 2004. PMID: 14560963 Review.
Cited by
-
Henriksen BS, Curtis ME, Fillmore N, Cardon BR, Thomson DM, Hancock CR. Henriksen BS, et al. Diabetol Metab Syndr. 2013 May 31;5:29. doi: 10.1186/1758-5996-5-29. eCollection 2013. Diabetol Metab Syndr. 2013. PMID: 23725555 Free PMC article.
-
Lomitapide repurposing for treatment of malignancies: A promising direction.
Wu HT, Wu BX, Fang ZX, Wu Z, Hou YY, Deng Y, Cui YK, Liu J. Wu HT, et al. Heliyon. 2024 Jun 13;10(12):e32998. doi: 10.1016/j.heliyon.2024.e32998. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 38988566 Free PMC article. Review.
-
Resveratrol inhibits protein translation in hepatic cells.
Villa-Cuesta E, Boylan JM, Tatar M, Gruppuso PA. Villa-Cuesta E, et al. PLoS One. 2011;6(12):e29513. doi: 10.1371/journal.pone.0029513. Epub 2011 Dec 29. PLoS One. 2011. PMID: 22242130 Free PMC article.
-
Left-right asymmetry in the light of TOR: An update on what we know so far.
Casar Tena T, Burkhalter MD, Philipp M. Casar Tena T, et al. Biol Cell. 2015 Sep;107(9):306-18. doi: 10.1111/boc.201400094. Epub 2015 Jun 11. Biol Cell. 2015. PMID: 25943139 Free PMC article. Review.
-
The mTOR signalling pathway in human cancer.
Pópulo H, Lopes JM, Soares P. Pópulo H, et al. Int J Mol Sci. 2012;13(2):1886-1918. doi: 10.3390/ijms13021886. Epub 2012 Feb 10. Int J Mol Sci. 2012. PMID: 22408430 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous